PRACTICAL USE OF MECHANISTIC MODELING TO DISCERN REAL WORD COMPLEX DRUG INTERACTIONS

被引:0
|
作者
Grillo, Joseph [1 ]
机构
[1] US FDA, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
S3.4
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Dealing with the complex drug-drug interactions: Towards mechanistic models
    Varma, Manthena V.
    Pang, K. Sandy
    Isoherranen, Nina
    Zhao, Ping
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (02) : 71 - 92
  • [2] A Mechanistic Modeling Framework for Predicting Metabolic Interactions in Complex Mixtures
    Cheng, Shu
    Bois, Frederic Y.
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2011, 119 (12) : 1712 - 1718
  • [3] Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide
    Varma, Manthena V. S.
    Lai, Yurong
    Kimoto, Emi
    Goosen, Theunis C.
    El-Kattan, Ayman F.
    Kumar, Vikas
    [J]. PHARMACEUTICAL RESEARCH, 2013, 30 (04) : 1188 - 1199
  • [4] Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide
    Manthena V. S. Varma
    Yurong Lai
    Emi Kimoto
    Theunis C. Goosen
    Ayman F. El-Kattan
    Vikas Kumar
    [J]. Pharmaceutical Research, 2013, 30 : 1188 - 1199
  • [5] Practical Assessment of Clinical Drug-Drug Interactions in Drug Development Using Physiologically Based Pharmacokinetics Modeling
    Shebley, Mohamad
    Einolf, Heidi J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (06) : 1326 - 1328
  • [6] Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions
    Baneyx, Guillaume
    Fukushima, Yumi
    Parrott, Neil
    [J]. FUTURE MEDICINAL CHEMISTRY, 2012, 4 (05) : 681 - 693
  • [7] MECHANISTIC PBPK MODELING OF CREATININE-DRUG INTERACTIONS IN CHRONIC KIDNEY DISEASE POPULATION.
    Takita, H.
    Scotcher, D.
    Chinnadurai, R.
    Kalra, P.
    Galetin, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S85 - S85
  • [8] MECHANISTIC PBPK MODELING OF CREATININE-DRUG INTERACTIONS IN CHRONIC KIDNEY DISEASE POPULATION.
    Takita, H.
    Scotcher, D.
    Chinnadurai, R.
    Kalra, P.
    Galetin, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S59 - S60
  • [9] Use of clearance concepts and modeling techniques in the prediction of metabolic drug-drug interactions
    Ito, Kiyomi
    Sugiyama, Yuichi
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (08) : 351 - 355
  • [10] Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions
    Greupink, Rick
    Schreurs, Marieke
    Benne, Marina S.
    Huisman, Maarten T.
    Russel, Frans G. M.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 49 (05) : 819 - 828